Who we are
We are Asklepion Pharmaceuticals, LLC., a biopharmaceutical company based in Baltimore, Maryland. In 2006, the need for drug research and development for both large patient populations and very small subsets of patients became the catalyst for creating this company. We have entered into partnerships with universities, other pharmaceutical companies, drug distributors, and financial assistance programs to build a firm foundation for products to be approved by the FDA and commercialized.
What we do
We focus on the development of treatments for rare pediatric diseases. Our pipeline currently focuses on rare and critical diseases in children. Asklepion strives to channel the powers of science and biotechnology into therapies that are life-saving and to significantly improve the quality of life for sick children and anxious parents. We commit ourselves to high ethical standards, scientific rigor, consistency, and accessibility so we can begin to build a better future for these children.
Our extraordinary work place
We are a small group of professionals in Baltimore. With dedication and collaboration, we have reached significant milestones as a company. One of our largest milestones was obtaining FDA approval for an oral treatment indicated for bile acid synthesis defects.
